Growth inhibition of cervical cancer cells by the human retinoic acid receptor β gene

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 289-295

  Geisen, Caroline ^a   Denk, Claudia ^a   Küpper, Jan Heiner ^a,b   Schwarz, Elisabeth ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REGULATORY MECHANISM; TRANSGENE; UTERINE CERVIX CARCINOMA;

ANIMALS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; HYBRID CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, RETINOIC ACID; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 0010378995     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<289::AID-IJC22>3.0.CO;2-T     Document Type: Article

References (21)

1. BARTSCH, D., BOYE, B., BAUST, C., ZUR HAUSEN, H., and SCHWARZ, E., Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J., 11, 2283-2291 (1992).
2. BAUST, C., REDPATH, L., and SCHWARZ, E., Different ligand responsiveness of human retinoic acid receptor β gene transcription in tumorigenic and nontumorigenic cervical carcinoma-derived cell lines is mediated through a large retinoic acid response domain. Int. J. Cancer, 67, 409-416 (1996).
3. BOLLAG, W., APFEL, C., and LEMOTTE, P., Retinoids: Achievements, prospectives and future goals. In S. Waxman (ed.), Differentiation therapy, challenges of modern medicine, Vol. 10, pp. 285-302, Ares-Serono Symposia Publications, Rome (1995).
4. DAMM, K., HEYMAN, R.A., UMESONO, K., and EVANS, R.M., Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. natl. Acad. Sci. (Wash.). 90, 2989-2993 (1993).
5. GEBERT, J. F., MOGHAL, N., FRANGIONI, J. V., SUGARBAKER, D. J., and NEEL, B. G., High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6, 1859-1868 (1991).
6. GEISEN, C., DENK, C., GREMM, B., BAUST, C., KARGER, A., BOLLAG, W., and SCHWARZ, E., High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res., 57, 1460-1467 (1997).
7. HONG, W. K., AND ITRI, L. M. Retinoids and human cancer. In M. B. Sporn, A. B. Roberts and D. S. Goodman (eds.), The retinoids: Biology, chemistry and medicine, pp. 597-630, Raven Press, New York (1994).
8. HOPPE-SEYLER, F., BUTZ, K., RITTMÜLLER, C., and VON KNEBEL DOEBERITZ, M., A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts. Nucleic Acids Res., 19, 5080 (1991).
9. HOULE, B., ROCHETTE-EGLY, C., and BRADLEY, W. E. C., Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. natl. Acad. Sci. (Wash.)., 90, 985-989 (1993).
10. HU, L., CROWE, D. L., RHEINWALD, J. G., CHAMBON, P., and GUDAS, L. J., Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res., 51, 3972-3981 (1991).
11. KAISER, A., HERBST, H., FISHER, G., KOENIGSMANN, M., BERDEL, W.E., RIECKEN, E.-O., and ROSEWICZ, S., Retinoic acid receptor β regulates growth and differentiation in human pancreatic carcinoma cells. Gastroenterology, 113, 920-929 (1997).
12. LANGENFELD, J., KIYOKAWA, H., SEKULA, D., BOYLE, J., and DMITROVSKY, E., Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc. natl. Acad. Sci. (Wash.), 94, 12070-12074 (1997).
13. LIU, Y., LEE, M.-O., WANG, H.-G., LI, Y., HASHIMOTO, Y., KLAUS, M., REED, J. C., and ZHANG, X.-K., Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. cell. Biol., 16, 1138-1149 (1996).
14. MANGELSDORF, D. J., UMESONO, K., and EVANS, R. M. The retinoid receptors. In M. B. Sporn, A. B., Roberts and D. S. Goodman (eds.), The retinoid receptors: Biology, chemistry, and medicine, pp. 319-349, Raven Press, New York (1994).
15. ROCHETTE-EGLY, C., GAUB, M.-P., LUTZ, Y., ALI, S., SCHEUER, I., and CHAMBON, P., Retinoic acid receptor-β: immunodetection and phosphorylation on tyrosine residues. Mol. Endocrinol., 6, 2197-2209 (1992).
16. SABICHI, A.L., HENDRICKS, D.T., BOBER, M.A., and BIRRER, M.J., Retinoic acid receptor β expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J. natl. Cancer Inst., 90, 597-605 (1998).
17. SWISSHELM, K., RYAN, K., LEE, X., TSOU, H. C., PEACOCKE, M., and SAGER, R., Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differentiation, 5, 133-141 (1994).
18. Kipl expression. Int. J. Cancer, 80, 935-943 (1999).
19. WOLFFE, A.P., Sinfull repression. Nature (Lond.), 387, 16-17 (1997).
20. XU, X.-C., RO, J. Y., LEE, J. S., SHIN, D. M., HONG, W. K., and LOTAN, R., Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res., 54, 3580-3587 (1994).
21. XU, X.C., STIER, U., ROSEWICZ, S., EL-NAGGAR, A.K., and LOTAN, R., Differential suppression of nuclear retinoic acid receptor β in pancreatic carcinoma. Int. J. Oncol., 8, 445-451 (1996).